The global smartphone market is on track for its worst year ever as the AI-driven memory shortage continues to hammer sales.

Boeing is increasing 737 production to 47 jets a month, up from 42, after consulting with the Federal Aviation Administration ...

Morgan Stanley analyst James Faucette has lowered Verra Mobility’s price target to $4 from $15 and kept an ‘Equal Weight’ ...

The United States market has shown robust performance with a 2.5% increase over the last week and a remarkable 26% rise in the past year, while earnings are projected to grow by 17% annually. In this ...

Citrulline, Maca Root, Pine Bark, Velvet Bean, and Saffron in a Men's Vitality and Stamina Supplement With a 60-Day ...

EXCLUSIVE: Punchup Live, the creator-owned live entertainment platform from Danny Frenkel and Alex Dajani, has launched a ...

LLY plans $3.83B in biotech buyouts to expand into vaccines and infectious diseases beyond obesity and diabetes.

Allegations of bullying and a "shouty" management style have ended Albert Manifold's tenure, leaving yet another leadership ...

The United States market has shown impressive growth, rising 2.5% over the last week and 26% over the past year, with earnings projected to increase by 17% annually. In this thriving environment, ...

The deal includes a $650 million base price plus up to $400 million in contingent consideration, and is contingent on ...

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does First Financial (FFIN) have what it takes? Let's find out.

Intensity Therapeutics Inc. (INTS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).